Stem cells, their niches, and their relationship to cancer are under intense investigation. Because tumors and metastases acquire selfrenewing capacity, mechanisms for their establishment may involve cell-cell interactions similar to those between stem cells and stem cell niches. On the basis of our studies in Caenorhabditis elegans, we introduce the concept of a ''latent niche'' as a differentiated cell type that does not normally contact stem cells nor act as a niche but that can, under certain conditions, promote the ectopic self-renewal, proliferation, or survival of competent cells that it inappropriately contacts. Here, we show that ectopic germ-line stem cell proliferation in C. elegans is driven by a latent niche mechanism and that the molecular basis for this mechanism is inappropriate Notch activation. Furthermore, we show that continuous Notch signaling is required to maintain ectopic germ-line proliferation. We highlight the latent niche concept by distinguishing it from a normal stem cell niche, a premetastatic niche and an ectopic niche. One of the important distinguishing features of this mechanism for tumor initiation is that it could operate in the absence of genetic changes to the tumor cell or the tumor-promoting cell. We propose that a latent niche mechanism may underlie tumorigenesis and metastasis in humans.
T
he Caenorhabditis elegans hermaphrodite germ line offers a simple system to investigate principles of stem cell biology, including the biology of interactions between stem cells and niches (1) (2) (3) (Fig. 1A) . A single somatic cell, the distal tip cell (DTC), acts as a germ-line stem cell niche. Distal tip cell-germ line interaction promotes germ-line self-renewal through a Notch signal transduction pathway, maintaining a pool of proliferating niche-associated germ-line stem cells. The Delta/Serrate/LAG-2 (DSL)-family ligands LAG-2 and APX-1 are expressed in the DTC and activate the GLP-1 Notch-family receptor in the germ line (4) (5) (6) . Elevating GLP-1/Notch signaling in the germ line results in a ''tumorous'' phenotype in which germ cells fail to differentiate and continue to proliferate (7) . Ablation of the DTC causes all germ cells to differentiate (8) . Alteration in the number or location of the DTCs early in development can seed new germ cell proliferation centers (8, 9) , demonstrating that the DTC functions as a stem cell niche.
The ''proximal proliferation'' (Pro) phenotype is a distinct hyperplastic phenotype in which two germ-line proliferation centers are seen in the adult: the normal niche-associated proliferative zone and a second ectopic zone situated at the opposite end of the oviduct, far from the normal niche. The two populations of proliferating germ cells-normal and ectopic-are separated by differentiated germ cells. At the ectopic site, the localized mass of cells undergoes uncontrolled proliferation. It is therefore referred to as a ''tumor'' (10) (Figs. 1 A and 2) .
The Pro phenotype can occur as a result of mutations in a number of different genes encoding proteins with unrelated functions (11) (12) (13) (14) (15) (16) (17) (18) (19) , and these genes act in distinct cell types, including cells of the somatic gonad and the germ line itself. Thus, whether a common cellular and molecular basis for proximal tumor formation could be found was unclear. Despite this, previous studies (15, 20) suggested that some Pro mutants share in common a delay in germ-line differentiation relative to somatic development. Therefore, we wondered whether a common cellular and molecular mechanism could be found to account for Pro tumor formation.
Here, we show that ectopic germ cell proliferation in C. elegans Pro mutants can be driven by a mechanism that we term the ''latent niche.'' We define a latent niche as a differentiated cell type that does not normally contact stem cells nor act as a niche but that can, under certain conditions, promote the inappropriate self-renewal, proliferation, or survival of competent cells with which it comes into contact. Our results demonstrate that the molecular mechanism for the latent niche leading to germ-line tumors is the inappropriate GLP-1/Notch activation from a proximal source of ligand. Out of the 10 C. elegans DSL-family ligands (21) , apx-1 and arg-1 are expressed in the latent niche and largely account for its latent niche activity, while dsl-5 also contributes. We further demonstrate that the identity of the DSL ligand is not important because LAG-2, the DTC signal for normal germ-line development, can substitute for APX-1 in the latent niche role. Finally, we find that Notch signaling driven by ligands from the latent niche both promote and maintain proximal germ-line tumors. We propose that a similar latent niche mechanism may underlie tumorigenesis and metastasis in humans.
Results
The C. elegans Pro phenotype occurs as a secondary consequence of different primary defects caused by certain mutations of hlh-12, pro-1, and glp-1, genes with unrelated function and different expression patterns. Yet each case is associated with a delay in germ-line differentiation. This delay leads to the same inappropriate cell-cell contact between mitotically competent germ-line progenitors and specific gonadal sheath cells (Fig. 1 A) . In early stages of wild-type larval hermaphrodite development, germ cells are within the range of niche influence and all are undifferentiated. During normal larval development, gonad arm extension occurs in response to two separable processes: DTC migration (also separable from the DTC niche function) and robust germ-line proliferation. Niche-associated cells remain undifferentiated whereas germ cells beyond a certain distance from the DTC differentiate. Thus, differentiated germ cells first appear during development farthest from the niche (Fig. 1 A) .
A critical sequence of events during codevelopment of the germ line and soma is that germ cells escape the niche influence and begin to differentiate before the birth of neighboring (proximal) somatic cells (proximal sheath cells; Fig. 1 A) . By contrast, in Pro mutants germ-line differentiation is delayed relative to somatic gonad development, and germ-line differentiation begins after the birth of neighboring somatic gonad cells. For example, in hlh-12 Pro animals, early DTC migration is impaired (Fig. 1 A) (18) . Consequently, the niche continues to influence germ cells, and differentiation is delayed. As a result, newly born proximal somatic sheath cells inappropriately contact undifferentiated germ cells. We postulated that these sheath cells might then act as a latent niche, promoting the self-renewal and proliferation of undifferentiated germ cells that they inappropriately contact. Eventually, sufficient spatial separation occurs between the two sources of proliferationpromoting signals (distal normal niche and proximal latent niche), allowing germ-line differentiation to occur between them. A similar delay in differentiation and subsequent inappropriate cell-cell interaction occurs in pro-1 and glp-1 Pro mutants, albeit as a result of different primary defects. The Pro phenotype in pro-1 is due to a distal sheath defect that interferes with early robust germ-line proliferation, whereas glp-1 Pro is due to a germ-line-autonomous defect that elevates GLP-1/Notch activity ( Fig. 1 A) (13, 15, 20, 22) . Previous studies showed that ablation of precursors to the proximal sheath cells could prevent tumor formation (22) . On the basis of these observations, we postulated that a signal emanating from the proximal sheath cells might act as a latent niche signal and promote ectopic germ-line proliferation in mutants where the signal is received inappropriately.
Because maintenance of germ-line stem cells requires Notch activity, we further reasoned that a DSL-family ligand, a conserved family of ligands for Notch receptors (21, 23) , might underlie ectopic germ-line proliferation in Pro mutants. To determine whether any of the 10 C. elegans predicted DSL ligands (21) could act as a latent niche signal, we asked which were expressed in the right cells (proximal sheath) at the right time (after germ-line differentiation begins) and whether reduction of their activity could suppress ectopic germ-line tumor formation.
We examined the expression patterns of reporters driven by promoter sequences from each of the predicted DSL ligands ( Table  S1 ) and found that two of them, apx-1 and arg-1, were expressed in the proximal sheath cells from the time that these cells are born in the mid-L4 stage. apx-1 reporters driven by a 9-kb region upstream of the apx-1 coding sequence [a nuclear-localized Papx-1::NLSlacZ (21) and Papx-1::GFP] show expression in the two proximal-most pairs of sheath cells and the four distal-most cells of the spermatheca (Fig. 1B) . We confirmed the identity of these cells by position and expression of CEH-18 ( Fig. S1 ) and lim-7::GFP (24, 25) . This expression pattern suggests that apx-1 may be required for other processes that depend on proper function of these cells. We also constructed and examined a Parg-1::GFP reporter and found that it is expressed in proximal sheath cells (Fig. 1B) . No gonad expression of similar reporters driven by the other DSL gene promoters was observed in the proximal sheath, including a dsl-5 reporter (Table S1 ), despite evidence of a functional role for this gene (see below). Thus, apx-1 and arg-1 are expressed in a subset of somatic gonad cells that contact only differentiated germ cells in the wild type but contact undifferentiated germ cells in Pro mutants (Fig. 1B) .
If a particular DSL ligand is important for promoting proximal germ-line tumor formation, then removal of the ligand should suppress tumor formation. We therefore asked whether reducing DSL ligand gene activity by RNAi would suppress the formation of proximal tumors (Table S2) . Because a lack of reporter gene expression does not preclude a functional role, each of the DSL ligand genes was tested for function in tumor formation. Our previous genetic and ablation studies suggested that pro-1(Pro) is most sensitive to removal of the proximal sheath (13, 15, 20, 22) . Therefore, we first tested whether depletion of each putative ligand-encoding gene would suppress tumor formation in the pro-1 background and then further examined these in the glp-1(Pro) mutant background (Table 1 , Mutants and/or L1 RNAi feeding and Table S2 ).
In short, we found the strongest RNAi effects with 3 of the 10 putative DSL ligand genes: apx-1 had the strongest effect on the penetrance of the pro-1 Pro phenotype, reducing it from 98% to 33%, whereas arg-1 and dsl-5 RNAi also suppressed Pro (to 48% and 71%, respectively; Table 1 , Mutants and/or L1 RNAi feeding and Table S2 ). Double mutant combinations of pro-1(na48) with arg-1 and dsl-5 null alleles showed stronger suppression (to 41% and 31%, respectively; Table 1 ; pro-1;apx-1 double mutant combination causes embryonic lethality). Remarkably, RNAi reduction of apx-1 in a pro-1;arg-1 double mutant completely suppressed tumor formation, suggesting that these two ligands together can account for the tumor-promoting activity from the proximal sheath in the pro-1 mutant (Table 1 , Mutants and/or L1 RNAi feeding) because ablation of the proximal sheath cells also abolishes tumor formation (22) . :lacZ was observed in 59%, 97%, and 100% of animals in Sh4, Sh5, and spermatheca, respectively (n ϭ 88). Expression from Papx-1::GFP was observed in 78%, 100%, and 100%, in Sh4, Sh5, and spermatheca, respectively (n ϭ 56). We observed a more dynamic gonad pattern for Parg-1::GFP. Expression was not observed in L2 or L3 gonads (n ϭ 12) and first appears in the sheath cells in the mid-L4, in Sh4 and Sh5 (12/12 gonad arms), and occasionally also in Sh3 (1/12). By the late L4, Sh4 and Sh5 continue to express Parg-1::GFP (6/6) with 2/6 also expressing the transgene in Sh1-3. In very young adults (before embryogenesis), expression remained in Sh4 and Sh5 in all animals but was less frequently observed in Sh1-3 (2/9 gonad arms). Finally, in adults bearing embryos (n ϭ 48 gonad arms), 25% showed no expression. Expression was observed in 73% of Sh4 -5, and 15% of these also showed expression in Sh3, whereas 2% showed more distal sheath expression. Tumor formation caused by elevated glp-1 activity in the glp-1(Pro) mutant glp-1(ar202) was also partially suppressed to the wild-type pattern upon reduction of apx-1 and arg-1 (to 50% and 91%, respectively, Table 1 ). Although depletion of dsl-5 by RNAi did not suppress glp-1(Pro), the dsl-5 null allele did contribute to suppression [74% versus 91% Pro with and without dsl-5(ok588) in glp-1(ar202);arg-1(th7) and 42% versus 76% Pro in glp-1(ar202);arg-1(th7);apx-1(RNAi) with and without dsl-5(ok588); Table 1 , Mutants and/or L1 RNAi feeding]. The strongest level of suppression is close to, but not as strong as, the 22% Pro observed previously by ablation of the proximal sheath (see ref. 22 ). Some differences in suppression of pro-1(na48) and glp-1(ar202) are likely attributable to a residual ligand-independent activity of glp-1(ar202). Other differences may also exist, such as ligand-specific sensitivity of the mutant receptor because the Pro phenotype of glp-1(ar202) is weakly suppressed by dsl-7(RNAi), whereas the otherwise more sensitive Pro phenotype of pro-1(na48) is not (Table S2) .
To further test our postulated mechanism of tumor formation (Fig. 1 A) , we examined the effect of apx-1(RNAi) in additional tumor-forming mutants. Consistent with our model, hlh-12 tumors are highly dependent on apx-1 and glp-1 activity (Table  1 , Mutants and/or L1 RNAi feeding and Fig. 2) . Finally, we asked whether reducing apx-1 activity suppressed tumor formation caused by loss of GLD-1, an RNA-binding protein that acts downstream of glp-1 in the germ line to promote differentiation. Tumors in gld-1 mutants are not associated with a delay in the onset of differentiation (26, 27) . Consistent with our model, GLD-1 tumor formation is not suppressed by a reduction in apx-1 activity (Table 1) . We conclude that in pro-1, glp-1, and hlh-12 Pro mutants DSL ligands are the key components of the latent niche activity. In particular, APX-1 and ARG-1 in the proximal sheath drive proximal germ-line tumor formation in germ cells as a result of an inappropriate juxtaposition of the proximal sheath with undifferentiated germ cells. To determine whether the specific identity of the DSL-family ligand was critical for its latent germ-line proliferationpromoting function, we tested whether LAG-2 could substitute for APX-1 in its latent niche function. We expressed lag-2 from the apx-1 promoter and observed the Pro phenotype in pro-1(na48) animals (still expressing endogenous apx-1(ϩ)). We then treated these animals with RNAi directed against endogenous apx-1 and observed that, whereas control siblings that lacked the transgene exhibited a strong reduction in the penetrance of the Pro phenotype, the prevalence of tumor formation in pro-1;apx-1(RNAi) animals expressing Papx-1::lag-2 was not reduced (Table 1 , L1 RNAi feeding and Fig. 3A) . Because the lag-2 transgene is driven from the same promoter as the apx-1 expression reporters, these results confirm that APX-1 activity in cells marked by reporter expression is sufficient for the latent niche activity. We conclude that the specific identity of the DSL ligand in the latent niche is not critical.
To determine whether activity of the latent niche ligand APX-1 or the Notch receptor (GLP-1) is required continuously to maintain ectopic proliferation, we interfered with their activity after tumor formation and asked whether the tumor cells differentiate. We reduced apx-1 or glp-1 activity by RNAi in adult pro-1 animals after a tumor had formed. Our results show that in over half of the gonad arms, ectopic germ-line tumor cells differentiated (Table 1 , Adult RNAi feeding and Fig. 3B ). These results demonstrate that maintenance of ectopic proliferating germ-line cells requires continuous Notch pathway activation.
Because stem cell niches both promote self-renewal and produce cells that retain the ability to differentiate, our results also suggest that the latent niche is acting similarly to a stem cell niche. We reasoned that if germ cells of the tumor were acting like normal stem cells, then they should undergo differentiation if they could move out of the range of the latent niche signal. Consistent with this hypothesis, we found evidence of ''reverse'' polarity such that germ cells of the proximal tumor appear to differentiate at the distal border of the tumor (Fig. S2) . Determining what drives the apparent uncontrolled growth in the proximal tumors relative to the DTC-associated distal germ line will be of interest.
We examined two additional indicators of normal differentiation using the adult RNAi ligand-withdrawal strategy in pro-1 mutants. In the wild type, a substantial proportion of female germ cells in meiotic prophase (that is, differentiated) undergo apoptosis (28) . We asked whether similar cell death could be observed in tumors undergoing differentiation. Indeed, we observe cell death after withdrawal of apx-1 or arg-1 (Table S3) . Finally, we examined the expression of GLD-1::GFP, a marker of differentiation (29, 30) . We observed an increased penetrance of GLD-1 reporter expression in the proximal germ line of pro-1 mutants after exposure to apx-1, arg-1, or dsl-5 RNAi (Table S3) . Taken together, these data indicate that proximal tumors deprived of the latent niche signal exhibit differentiation features similar to those of germ cells differentiating from the normal stem cell niche.
Discussion
The data presented here provide evidence that inappropriate cell proliferation can be maintained by a latent niche mechanism. The ectopic proliferation examined here results from three independent genetic defects (hlh-12, pro-1, and glp-1) that affect three different cell types (DTC, sheath, and germ line, respectively). Each causes a delay in germ-line differentiation, resulting in inappropriate cell-cell contact that revealed the presence of a latent niche. Reducing DSL signals from the latent niche suppressed ectopic germ-line proliferation. Thus, the latent niche model provides a unifying cellular and molecular mechanism for tumor formation in these mutants. In addition, the maintenance of ectopic germ-line tumors was dependent on continuous signaling from the latent niche. (43) libraries, respectively. † Control RNAi is the L4440 Љempty vectorЉ plasmid in E. coli HT115. ‡ Penetrance of Pro was scored as a percentage of animals displaying a severe Mig defect (includes incomplete anterior or posterior migration up to those that had just completed the dorsal turn). For hlh-12(ok1532), 100% displayed some Mig defect, 62% of which were considered severe. § Homozygous glp-1(ar202); apx-1(or3) mutants were progeny of heterozygous mothers of the genotype glp-1(ar202);apx-1(or3)/nT1͓qIs51͔. The or3 allele encodes a C334Y missense mutation. The or3 allele is likely a stronger loss-of-function allele than zu183 [a transposon insertion in the 3Ј UTR (44)]. Double mutant pro-1(na48);apx-1(or3) animals were not viable. ¶ Sibling animals of both genotypes (with and without naEx152, and segregating from mothers of the genotype pro-1(na48); naEx152͓P apx-1::lag-2͔) were scored from L4440 control or apx-1 RNAi. ʈ Individual Pro gonad arms 1 day after transfer to indicated RNAi treatment; see Fig. 3B . ** , † † For statistics, all experiments compared to relevant negative controls in the same experimental set gave P Ͻ 0.001 in a one-sided Fisher exact test with the exception of ** where P Ͻ 0.05 and † † where no significant differences were observed (P Ͼ 0.3).
We propose the latent niche mechanism as a general paradigm for tumorigenesis whereby a cancer stem cell (or ''tumorpropagating cell'') or any renewal-competent cell contacts a latent niche to seed a new tumor or metastasis (Fig. 3C) . The latent niche differs conceptually from a ''premetastatic niche'' in that the activity of the latent niche need not be induced by a primary tumor (e.g., ref. 31). It differs from an ectopic niche (e.g., ref . 32) in that the cell providing the self-renewal signal is normal. It also differs from the role of stromal cells recruited into a tumor (e.g., ref. 33) in that the latent niche can retain its normal anatomical position and function and need not be recruited into the tumor to promote self-renewal. Finally, the latent niche differs from a normal stem cell niche that is vacated and repopulated (34, 35) in that normally the latent niche does not act as a niche. Nonetheless, a latent niche mechanism may act in conjunction with these mechanisms, other tumor-cell-autonomous mechanisms, or both to promote inappropriate self-renewal of neighboring cells. For example, Podsypanina et al. recently demonstrated that under experimental conditions normal mammary cells can persist in the lung for extended periods and subsequently become foci for new tumor growth when they are transformed (36) . It is conceivable that they are maintained by a latent niche mechanism and that self-renewal or survival signals could predispose such cells to progress to tumors after the acquisition of subsequent transforming mutations (36, 37) .
An important aspect of this proposed mechanism is that neither the tumor cells nor the latent niche cells need be genetically compromised to initiate or sustain a tumor. That is, proliferationcompetent cells need only contact a latent niche. As in our system, this feature implies that developmental defects-be they genetically or environmentally induced-could lead to tumor-promoting inappropriate cell-cell contacts. This feature further suggests a mechanism whereby nongenetic anatomical defects could promote tumorigenesis, such as anatomical changes after surgery or injury, or shifts in cell-cell contacts during normal processes such as aging.
Determining whether a similar latent niche mechanism contributes to tumor initiation or metastasis in humans will be of interest. Conceivably, self-renewal signals, even different ligands of the same family that activate potentially oncogenic receptors, could be present in a latent form in many tissue types and could contribute to preferential sites of tumor or metastasis ''seeding'' (38) . If so, then latent niches and the signals that they produce may constitute new therapeutic targets.
Materials and Methods
Plasmids. Plasmids were constructed using standard methods; all pPD vectors used are from the Fire laboratory vector kit available from Addgene (A Fire, S Xu, J Fleenor, J Ahnn, and G Seydoux, personal communication Worm Methods. Standard methods were used for worm husbandry and genetics (41) . naEx152, naEx156, and naEx180 were generated by injection of 100 ng/L pRF4 as a transformation marker in addition to pGC398, pGC399 (each at 1 ng/L), and pGC474 (10 ng/L), respectively. Existing strains used: wild type (N2), GC585 pro-1(na48)/mIn1 [dpy-10(e128) -1(na48)/mIn1[mIs14 dpy-10(e128)];dsl-5(ok588), GC1090  glp-1(ar202);dsl-5(ok588);arg-1(th7) .
10(e128)], GC1074 pro
arg-1(th7) deletes 853 bp in the arg-1 locus, including exons 1-3 that encode the DSL protein motif, and is flanked by sequences: TACGTTGCTTGTTTTTGGC-TATCG… CCACAATGCACAGCAGTATGAC. It was detected by PCR product size using primers AGTAGCATCACTGCTTGTCA and ATCAGTCCATCTTCGGGCCT and by failure to generate a product from a primer pair internal (TGGAGCACAG-GAAAATGGTG) and external (AGTAGCATCACTGCTTGTCA) to the deletion.
dsl-5(ok588) was detected by PCR product size generated with primers ATT-GGTGTCGCTTTCCTTTG and TGTACGGGTTCGAACATTCA and for failure to generate a product with primers TGTACGGGTTCGAACATTCA (external) and AAG-GTCTGGCTACAGCAGCC (internal) to the deletion.
RNAi. L1 animals were grown at 20°C, synchronized, placed on RNAi-inducing bacteria, shifted to 25°C, fixed, and DAPI-stained 2 days later.
For adult RNAi, synchronized L1 GC585 animals were grown on L4440-containing bacteria and shifted to 25°C. As young adults, individuals were imaged and then placed on L4440, apx-1(RNAi) [pGC304; (6) ] or glp-1(RNAi) (42) . The same gonad arm of the same individual was imaged 1 day later. Additional methods can be found in SI Methods.
